Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenelinkGNLKQ Pretax Margin % is 0.00% as of Sep. 2013.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Genelink's Pre-Tax Income for the
three
months ended in Sep. 2013 was $0.00 Mil. Genelink's Revenue for the
three
months ended in Sep. 2013 was $0.30 Mil. Therefore, Genelink's pretax margin for the quarter that ended in Sep. 2013 was 0.00%.
The historical rank and industry rank for Genelink's Pretax Margin % or its related term are showing as below:
GNLKQ's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.1 * Ranked among companies with meaningful Pretax Margin % only.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Genelink Pretax Margin % Related Terms
Genelink Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Genelink's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNLKQ vs VITIF, HSTC, NTRR: Pretax Margin % Comparison
For the Biotechnology subindustry, Genelink's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genelink Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genelink's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Genelink's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genelink (GNLKQ) has a Pretax Margin % of 0.00% as of Sep. 2013. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Genelink and its competitors.
Is Genelink's Pretax Margin % too high?
Genelink's current Pretax Margin % is 0.00%.
How does Genelink's Pretax Margin % compare to VITIF and HSTC?
Genelink's Pretax Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Genelink and its competitors. Genelink's current Pretax Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelink stock overvalued right now?
Genelink (GNLKQ) has a current Pretax Margin % of 0.00%. The current Pretax Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Genelink (GNLKQ), the current Pretax Margin % is 0.00% as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genelink Inc is a genetics-based, personal healthcare firm that has developed DNA assessments measuring personal DNA tendencies. These small differences in DNA, called SNPs can indicate genetic variants, the protein products of which may not be performing at optimal levels and can be linked to aging and other wellness issues. The company's scientists use the DNA assessments information from each client to formulate products to optimize health and wellness within normal ranges. The company has a compilation of issued and pending patents that center on using DNA analysis for the purpose of customizing nutrition and skin care formulations for wellness and anti-aging.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNLKQ has been successfully added to your 
